Introduction Nitrosamine Testing for Pharmaceutical Drugs has become an essential part of modern drug development and quality control. It is […]
Why Nitrosamine Testing is Non-Negotiable for Pharmaceutical Drugs Read More »
INTRODUCTION Outsourcing to a U.S.-based Extractables and Leachables (E&L) testing laboratory in the United States helps pharmaceutical and biotech companies
Choosing the right ICH Q3E Extractables & Leachables (E&L) Testing Laboratory is one of the most important decisions a sponsor
Introduction The new guideline ICH Q3E Extractables & Leachables (E&L) for Medical Devices represents a major step toward global alignment
ICH Q3E for Medical Devices and Combination Products: How E&L Requirements are Evolving Read More »
INTRODUCTION The ICH Q3E Extractables and Leachables (E&L) study requirements outline a unified regulatory expectation for evaluating chemical migrants from
The ICH Q3E Extractables & Leachables (E&L) Risk Assessment provides a global structure to ensure that materials, components, and manufacturing
ICH Q3E Extractables and Leachables (E&L) Testing Services are essential for showing that packaging materials, device parts, and manufacturing components
INTRODUCTION The ICH Q3E guideline for Extractables and Leachables provides the international standard for evaluating chemical compounds that may migrate
ICH Q3E Guideline for Extractables and Leachables: Complete Technical Breakdown for 2025 Read More »
INTRODUCTION Extractables and Leachables (E&L) Testing in the USA vs. Europe: Regulatory Differences is one of the most crucial topics
Extractables and Leachables (E&L) Testing in the USA vs. Europe: Regulatory Differences Read More »
Introduction Extractables and Leachables Carcinogenicity Testing plays a vital role in protecting patients who rely on modern pharmaceuticals, biopharmaceuticals, and
The Role of Extractables and Leachables (E&L) in Carcinogenicity Risk Read More »
